See more : Bhartiya International Ltd. (BIL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Core Laboratories N.V. (CLB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Core Laboratories N.V., a leading company in the Oil & Gas Equipment & Services industry within the Energy sector.
You may be interested
- Harvia Oyj (HRVFF) Income Statement Analysis – Financial Results
- Kaisa Prosperity Holdings Limited (2168.HK) Income Statement Analysis – Financial Results
- Polaris Group (6550.TW) Income Statement Analysis – Financial Results
- FuelCell Energy, Inc. (0A60.L) Income Statement Analysis – Financial Results
- York Timber Holdings Limited (YRK.JO) Income Statement Analysis – Financial Results
Core Laboratories N.V. (CLB)
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 509.79M | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M | 659.81M | 594.74M | 797.52M | 1.09B | 1.07B | 981.08M | 907.65M | 794.65M | 695.54M | 780.84M | 670.54M | 575.69M | 483.47M | 427.43M | 405.64M | 364.75M | 376.57M | 336.10M | 303.70M | 286.20M | 214.90M | 105.40M | 80.10M |
| Cost of Revenue | 415.74M | 410.82M | 386.41M | 395.63M | 518.18M | 520.05M | 499.18M | 469.52M | 560.11M | 691.97M | 688.44M | 644.74M | 593.37M | 513.79M | 457.77M | 514.78M | 449.19M | 407.10M | 368.12M | 336.39M | 326.92M | 301.31M | 293.31M | 268.66M | 245.40M | 220.50M | 170.50M | 84.70M | 64.20M |
| Gross Profit | 94.05M | 78.92M | 83.84M | 91.63M | 150.03M | 180.80M | 160.63M | 125.23M | 237.41M | 393.26M | 385.07M | 336.34M | 314.28M | 280.86M | 237.77M | 266.05M | 221.35M | 168.59M | 115.34M | 91.04M | 78.72M | 63.44M | 83.26M | 67.44M | 58.30M | 65.70M | 44.40M | 20.70M | 15.90M |
| Gross Profit Ratio | 18.45% | 16.11% | 17.83% | 18.81% | 22.45% | 25.80% | 24.34% | 21.06% | 29.77% | 36.24% | 35.87% | 34.28% | 34.63% | 35.34% | 34.18% | 34.07% | 33.01% | 29.28% | 23.86% | 21.30% | 19.41% | 17.39% | 22.11% | 20.07% | 19.20% | 22.96% | 20.66% | 19.64% | 19.85% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 40.26M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | -1.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 38.89M | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 41.14M | 33.03M | 30.37M | 31.65M | 33.84M | 33.08M | 37.85M | 28.14M | 22.79M | 20.18M | 15.93M | 13.54M | 12.30M | 8.40M | 6.00M | 3.60M | 2.70M |
| Other Expenses | 515.00K | -722.00K | 5.60M | -1.83M | -5.32M | 737.00K | -452.00K | 344.00K | -3.67M | -1.07M | 338.00K | 4.12M | 22.38M | 20.91M | 20.62M | 28.54M | 3.66M | 11.95M | 16.57M | 16.38M | 22.61M | 22.50M | 27.78M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
| Operating Expenses | 39.41M | 37.40M | 44.17M | 34.03M | 48.02M | 62.91M | 47.74M | 39.39M | 49.73M | 45.66M | 51.99M | 43.19M | 63.53M | 53.94M | 50.99M | 60.19M | 37.50M | 45.03M | 54.41M | 44.52M | 45.40M | 42.68M | 43.71M | 32.76M | 31.00M | 24.90M | 17.00M | 8.20M | 5.80M |
| Cost & Expenses | 455.15M | 448.21M | 430.59M | 429.67M | 566.21M | 582.96M | 546.92M | 508.91M | 609.84M | 737.62M | 740.43M | 687.92M | 656.89M | 567.73M | 508.76M | 574.97M | 486.69M | 452.13M | 422.54M | 380.91M | 372.32M | 343.99M | 337.02M | 301.41M | 276.40M | 245.40M | 187.50M | 92.90M | 70.00M |
| Interest Income | 0.00 | 11.57M | 9.15M | 14.37M | 14.69M | 0.00 | 0.00 | 0.00 | 56.00K | 403.00K | 776.00K | 319.00K | 138.00K | 249.00K | 0.00 | 848.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 13.43M | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M | 10.73M | 11.57M | 12.38M | 10.60M | 9.32M | 8.82M | 10.90M | 15.84M | 15.52M | 6.43M | 0.00 | 0.00 | 0.00 | 0.00 | 7.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 15.78M | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M | 24.52M | 26.87M | 27.46M | 26.70M | 25.47M | 22.92M | 23.30M | 23.27M | 24.33M | 21.77M | 19.48M | 17.69M | 17.06M | 17.40M | 23.54M | 20.10M | 22.54M | 19.22M | 18.70M | 16.50M | 11.00M | 4.60M | 3.10M |
| EBITDA | 70.42M | 58.69M | 63.78M | -56.50M | 119.29M | 141.71M | 134.49M | 114.32M | 188.53M | 373.23M | 358.89M | 316.54M | 271.47M | 247.72M | 210.60M | 231.66M | 203.32M | 141.25M | 77.99M | 63.66M | 56.16M | 40.52M | 62.09M | 53.75M | 39.16M | 57.01M | 41.70M | 17.10M | 13.20M |
| EBITDA Ratio | 13.81% | 11.98% | 13.56% | 15.73% | 17.85% | 20.22% | 20.82% | 14.49% | 23.07% | 31.93% | 31.06% | 30.30% | 30.19% | 31.48% | 30.35% | 29.26% | 28.04% | 23.65% | 17.41% | 14.77% | 13.79% | 11.86% | 18.67% | 15.77% | 19.89% | 20.34% | 17.36% | 16.03% | 16.35% |
| Operating Income | 54.64M | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M | 112.44M | 86.18M | 161.07M | 346.53M | 333.42M | 297.28M | 250.75M | 226.93M | 186.78M | 206.71M | 183.85M | 123.56M | 60.93M | 46.51M | 33.32M | 20.76M | 36.58M | 34.69M | 27.30M | 40.80M | 27.40M | 12.50M | 10.10M |
| Operating Income Ratio | 10.72% | 8.48% | 9.63% | 11.45% | 14.47% | 16.93% | 17.04% | 14.49% | 20.20% | 31.93% | 31.06% | 30.30% | 27.63% | 28.56% | 26.85% | 26.47% | 27.42% | 21.46% | 12.60% | 10.88% | 8.21% | 5.69% | 9.71% | 10.32% | 8.99% | 14.26% | 12.75% | 11.86% | 12.61% |
| Total Other Income/Expenses | -13.43M | -11.57M | -9.15M | -14.37M | -14.69M | -13.33M | -8.26M | -11.57M | -12.38M | -10.60M | -9.32M | -8.82M | -11.91M | -17.78M | -15.52M | 1.55M | -2.55M | -5.81M | -14.29M | -8.28M | -5.07M | -5.38M | -7.92M | -8.31M | -8.56M | -3.92M | -2.60M | -1.30M | -2.80M |
| Income Before Tax | 41.21M | 29.95M | 36.11M | -91.18M | 81.99M | 105.29M | 101.71M | 74.61M | 148.69M | 335.93M | 324.10M | 288.46M | 238.84M | 209.15M | 171.26M | 208.61M | 181.30M | 117.75M | 46.64M | 38.24M | 25.62M | 13.16M | 28.66M | 27.36M | 5.10M | 33.70M | 22.00M | 11.40M | 7.30M |
| Income Before Tax Ratio | 8.08% | 6.12% | 7.68% | -18.71% | 12.27% | 15.02% | 15.41% | 12.54% | 18.64% | 30.96% | 30.19% | 29.40% | 26.31% | 26.32% | 24.62% | 26.72% | 27.04% | 20.45% | 9.65% | 8.95% | 6.32% | 3.61% | 7.61% | 8.14% | 1.68% | 11.77% | 10.24% | 10.82% | 9.11% |
| Income Tax Expense | 4.19M | 10.30M | 15.89M | 5.90M | -12.29M | 25.45M | 18.61M | 10.75M | 33.76M | 77.31M | 80.91M | 71.85M | 54.20M | 63.75M | 57.16M | 65.00M | 60.19M | 35.09M | 14.93M | 10.22M | 6.92M | 5.53M | 8.02M | 8.21M | 1.70M | 10.10M | 6.60M | 3.70M | 2.20M |
| Net Income | 36.68M | 19.45M | 19.73M | -97.07M | 101.98M | 79.53M | 83.13M | 63.90M | 114.85M | 257.49M | 242.81M | 216.07M | 184.68M | 144.92M | 113.60M | 143.60M | 121.11M | 82.66M | 31.21M | 12.29M | 18.70M | -9.06M | 20.63M | 19.15M | 3.40M | 20.00M | 15.40M | 7.70M | 4.20M |
| Net Income Ratio | 7.19% | 3.97% | 4.19% | -19.92% | 15.26% | 11.35% | 12.60% | 10.74% | 14.40% | 23.73% | 22.62% | 22.02% | 20.35% | 18.24% | 16.33% | 18.39% | 18.06% | 14.36% | 6.46% | 2.88% | 4.61% | -2.48% | 5.48% | 5.70% | 1.12% | 6.99% | 7.17% | 7.31% | 5.24% |
| EPS | 0.79 | 0.42 | 0.51 | -2.18 | 2.11 | 1.80 | 1.88 | 1.45 | 2.71 | 5.90 | 5.38 | 4.66 | 3.99 | 3.23 | 2.47 | 2.85 | 2.58 | 1.65 | 0.60 | 0.23 | 0.31 | -0.14 | 0.31 | 0.28 | 0.04 | 0.30 | 0.31 | 0.18 | 0.11 |
| EPS Diluted | 0.77 | 0.42 | 0.50 | -2.16 | 2.10 | 1.79 | 1.88 | 1.45 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3.00 | 2.43 | 2.74 | 2.48 | 1.54 | 0.56 | 0.22 | 0.30 | -0.14 | 0.30 | 0.27 | 0.04 | 0.29 | 0.30 | 0.17 | 0.11 |
| Weighted Avg Shares Out | 46.68M | 46.33M | 46.01M | 44.48M | 44.36M | 44.21M | 44.15M | 43.48M | 42.38M | 43.64M | 45.10M | 46.35M | 46.29M | 44.83M | 45.94M | 46.02M | 47.07M | 50.31M | 52.08M | 53.79M | 60.42M | 66.35M | 66.15M | 64.78M | 62.90M | 58.45M | 50.32M | 43.43M | 40.00M |
| Weighted Avg Shares Out (Dil) | 47.52M | 46.81M | 46.69M | 44.97M | 44.65M | 44.47M | 44.26M | 44.15M | 42.91M | 44.60M | 45.99M | 47.55M | 48.39M | 48.24M | 46.66M | 47.89M | 48.82M | 53.78M | 56.02M | 57.52M | 62.36M | 66.35M | 68.54M | 67.08M | 64.89M | 60.50M | 52.00M | 44.71M | 40.00M |
BKR or CLB: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Oil and Gas - Field Services sector have probably already heard of Baker Hughes (BKR) and Core Laboratories (CLB). But which of these two companies is the best option for those looking for undervalued...
Core Laboratories (CLB) Q2 Earnings Beat & Revenues Lag
Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.
What's in Store for Core Laboratories (CLB) in Q2 Earnings?
Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BKR or CLB: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider either Baker Hughes (BKR) or Core Laboratories (CLB). But which of these two stocks offers value investors a better bang for their buck...
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Natixis Advisors L.P. Cuts Holdings in Core Laboratories Inc. (NYSE:CLB)
Natixis Advisors L.P. decreased its position in Core Laboratories Inc. (NYSE:CLB – Free Report) by 32.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,928 shares of the oil...
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
Source: https://incomestatements.info
Category: Stock Reports